These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Drug-drug interaction study to assess the effects of atorvastatin co-administration on pharmacokinetics and anti-thrombotic properties of cilostazol in male Wistar rats. Vats R, Varanasi KV, Arla R, Veeraraghvan S, Rajak S. Biopharm Drug Dispos; 2012 Nov; 33(8):455-65. PubMed ID: 22936637 [Abstract] [Full Text] [Related]
23. Antithrombotic activity of argan oil: an in vivo experimental study. Mekhfi H, Belmekki F, Ziyyat A, Legssyer A, Bnouham M, Aziz M. Nutrition; 2012 Sep; 28(9):937-41. PubMed ID: 22465906 [Abstract] [Full Text] [Related]
24. Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative. Jin YR, Hwang KA, Cho MR, Kim SY, Kim JH, Ryu CK, Son DJ, Park YH, Yun YP. Vascul Pharmacol; 2004 Feb; 41(1):35-41. PubMed ID: 15135330 [Abstract] [Full Text] [Related]
26. Antiplatelet and antithrombotic effects of a combination of ticlopidine and ginkgo biloba ext (EGb 761). Kim YS, Pyo MK, Park KM, Park PH, Hahn BS, Wu SJ, Yun-Choi HS. Thromb Res; 1998 Jul 01; 91(1):33-8. PubMed ID: 9700851 [Abstract] [Full Text] [Related]
27. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor. Vilahur G, Pena E, Padró T, Badimon L. Thromb Haemost; 2007 Apr 01; 97(4):650-7. PubMed ID: 17393029 [Abstract] [Full Text] [Related]
28. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis. Karnicki K, Leadley RJ, Baxi S, Peterson T, Wysokinski W, McBane RD. Thromb Haemost; 2008 Apr 01; 99(4):759-66. PubMed ID: 18392334 [Abstract] [Full Text] [Related]
29. Effect of cilostazol on platelet aggregation and experimental thrombosis. Kimura Y, Tani T, Kanbe T, Watanabe K. Arzneimittelforschung; 1985 Apr 01; 35(7A):1144-9. PubMed ID: 4074426 [Abstract] [Full Text] [Related]
30. A randomized crossover comparative study of aspirin, cilostazol and clopidogrel in normal controls: analysis with quantitative bleeding time and platelet aggregation test. Kim JS, Lee KS, Kim YI, Tamai Y, Nakahata R, Takami H. J Clin Neurosci; 2004 Aug 01; 11(6):600-2. PubMed ID: 15261228 [Abstract] [Full Text] [Related]
31. Studies on the antithrombotic and antiplatelet activities of NQ304, a newly synthesized naphthoquinone derivative. Yuk DY, Lee HY, Ryu CK, Hong JT, Kang WS, Yoo HS, Yun YP. Arzneimittelforschung; 2000 Mar 01; 50(3):254-9. PubMed ID: 10758777 [Abstract] [Full Text] [Related]
32. Anti-thrombosis effect of diosgenyl saponins in vitro and in vivo. Zhang R, Huang B, Du D, Guo X, Xin G, Xing Z, Liang Y, Chen Y, Chen Q, He Y, Huang W. Steroids; 2013 Nov 01; 78(11):1064-70. PubMed ID: 23891646 [Abstract] [Full Text] [Related]
36. Antiplatelet and antithrombotic activities of salvianolic acid A. Fan HY, Fu FH, Yang MY, Xu H, Zhang AH, Liu K. Thromb Res; 2010 Jul 01; 126(1):e17-22. PubMed ID: 20451955 [Abstract] [Full Text] [Related]